PDGFR-alpha Inhibits Melanoma Growth Via CXCL10/IP-10: a Multi-omics Approach

Overview

Journal Oncotarget

Specialty Oncology

Date 2016 Oct 21

PMID 27764787

Citations 19

Authors

Daniela DArcangelo

Francesco Facchiano

Giovanni Nassa

Andrea Stancato

Annalisa Antonini

Stefania Rossi

Cinzia Senatore

Martina Cordella

Claudio Tabolacci

Annamaria Salvati

Roberta Tarallo

Alessandro Weisz

Angelo M Facchiano

Antonio Facchiano

Affiliations

Soon will be listed here.

Abstract

Melanoma is the most aggressive skin-cancer, showing high mortality at advanced stages. Platelet Derived Growth Factor Receptor-alpha (PDGFR-alpha) potently inhibits melanoma- and endothelium-proliferation and its expression is significantly reduced in melanoma-biopsies, suggesting that melanoma progression eliminates cells expressing PDGFR-alpha. In the present study transient overexpression of PDGFR-alpha in endothelial (HUVEC) and melanoma (SKMel-28, A375, Preyer) human-cells shows strong anti-proliferative effects, with profound transcriptome and miRNome deregulation. PDGFR-alpha overexpression strongly affects expression of 82 genes in HUVEC (41 up-, 41 down-regulated), and 52 genes in SKMel-28 (43 up-, 9 down-regulated). CXCL10/IP-10 transcript showed up to 20 fold-increase, with similar changes detectable at the protein level. miRNA expression profiling in cells overexpressing PDGFR-alpha identified 14 miRNAs up- and 40 down-regulated, with miR-503 being the most down-regulated (6.4 fold-reduction). miR-503, miR-630 and miR-424 deregulation was confirmed by qRT-PCR. Interestingly, the most upregulated transcript (i.e., CXCL10/IP-10) was a validated miR-503 target and CXCL10/IP-10 neutralization significantly reverted the anti-proliferative action of PDGFR-alpha, and PDGFR-alpha inhibition by Dasatinb totally reverted the CXCL10/IP10 induction, further supporting a functional interplay of these factors. Finally, integration of transcriptomics and miRNomics data highlighted several pathways affected by PDGFR-alpha.This study demonstrates for the first time that PDGFR-alpha strongly inhibits endothelial and melanoma cells proliferation in a CXCL10/IP-10 dependent way, via miR-503 down-regulation.

Citing Articles

A novel prognostic signature of chemokines for survival and immune infiltration in kidney renal clear cell carcinoma.

Weng J, Huang Z, Li Q, Huang Y, Chen S Int J Med Sci. 2023; 20(8):1046-1059.

PMID: 37484803 PMC: 10357446. DOI: 10.7150/ijms.84940.

Noncoding RNA circuitry in melanoma onset, plasticity, and therapeutic response.

Grafanaki K, Grammatikakis I, Ghosh A, Gopalan V, Olgun G, Liu H Pharmacol Ther. 2023; 248:108466.

PMID: 37301330 PMC: 10527631. DOI: 10.1016/j.pharmthera.2023.108466.

Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.

Qu G, Wang H, Yan H, Liu G, Wu M Front Oncol. 2022; 12:857619.

PMID: 35296026 PMC: 8918693. DOI: 10.3389/fonc.2022.857619.

Systems biology of angiogenesis signaling: Computational models and omics.

Zhang Y, Wang H, Oliveira R, Zhao C, Popel A WIREs Mech Dis. 2021; 14(4):e1550.

PMID: 34970866 PMC: 9243197. DOI: 10.1002/wsbm.1550.

Targeting Melanoma-Initiating Cells by Caffeine: In Silico and In Vitro Approaches.

Tabolacci C, Cordella M, Rossi S, Bonaccio M, Eramo A, Mischiati C Molecules. 2021; 26(12).

PMID: 34199192 PMC: 8231844. DOI: 10.3390/molecules26123619.

References

Facchiano A, De Marchis F, Turchetti E, Facchiano F, Guglielmi M, Denaro A . The chemotactic and mitogenic effects of platelet-derived growth factor-BB on rat aorta smooth muscle cells are inhibited by basic fibroblast growth factor. J Cell Sci. 2000; 113 ( Pt 16):2855-63. DOI: 10.1242/jcs.113.16.2855. View

DArcangelo D, Gaetano C, Capogrossi M . Acidification prevents endothelial cell apoptosis by Axl activation. Circ Res. 2002; 91(7):e4-12. DOI: 10.1161/01.res.0000036753.50601.e9. View

Hsiao J, Fisher D . The roles of microphthalmia-associated transcription factor and pigmentation in melanoma. Arch Biochem Biophys. 2014; 563:28-34. PMC: 4336945. DOI: 10.1016/j.abb.2014.07.019. View

Willenberg A, Saalbach A, Simon J, Anderegg U . Melanoma cells control HA synthesis in peritumoral fibroblasts via PDGF-AA and PDGF-CC: impact on melanoma cell proliferation. J Invest Dermatol. 2011; 132(2):385-93. DOI: 10.1038/jid.2011.325. View

Farhana L, Dawson M, Murshed F, Das J, Rishi A, Fontana J . Upregulation of miR-150* and miR-630 induces apoptosis in pancreatic cancer cells by targeting IGF-1R. PLoS One. 2013; 8(5):e61015. PMC: 3651232. DOI: 10.1371/journal.pone.0061015. View

Huang Y, Guerrero-Preston R, Ratovitski E . Phospho-ΔNp63α-dependent regulation of autophagic signaling through transcription and micro-RNA modulation. Cell Cycle. 2012; 11(6):1247-59. PMC: 3335921. DOI: 10.4161/cc.11.6.19670. View

Tanese K, Grimm E, Ekmekcioglu S . The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: its impact on the chemokine expression profile, including suppression of CXCL10. Int J Cancer. 2011; 131(4):891-901. PMC: 3269542. DOI: 10.1002/ijc.26451. View

Facchiano A, Russo K, Facchiano A, De Marchis F, Facchiano F, Ribatti D . Identification of a novel domain of fibroblast growth factor 2 controlling its angiogenic properties. J Biol Chem. 2002; 278(10):8751-60. DOI: 10.1074/jbc.M209936200. View

Najy A, Won J, Movilla L, Kim H . Differential tumorigenic potential and matriptase activation between PDGF B versus PDGF D in prostate cancer. Mol Cancer Res. 2012; 10(8):1087-97. PMC: 3929081. DOI: 10.1158/1541-7786.MCR-12-0071. View

10.

Kobayashi H, Nobeyama Y, Nakagawa H . Tumor-suppressive effects of natural-type interferon-β through CXCL10 in melanoma. Biochem Biophys Res Commun. 2015; 464(2):416-21. DOI: 10.1016/j.bbrc.2015.06.122. View

11.

Christiaansen A, Varga S, Spencer J . Viral manipulation of the host immune response. Curr Opin Immunol. 2015; 36:54-60. PMC: 4593765. DOI: 10.1016/j.coi.2015.06.012. View

12.

Luo J, Peng Y, Chen T, Huo T, Hou M, Huang H . Clopidogrel inhibits angiogenesis of gastric ulcer healing via downregulation of vascular endothelial growth factor receptor 2. J Formos Med Assoc. 2015; 115(9):764-72. DOI: 10.1016/j.jfma.2015.07.022. View

13.

Chang S, Yue J, Wang B, Zhang X . miR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3. Int J Clin Exp Pathol. 2016; 8(10):12853-60. PMC: 4680421. View

14.

Lindell D, Lane T, Lukacs N . CXCL10/CXCR3-mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8(+) T cell efficacy. Eur J Immunol. 2008; 38(8):2168-79. PMC: 2743117. DOI: 10.1002/eji.200838155. View

15.

Chamorro-Jorganes A, Araldi E, Penalva L, Sandhu D, Fernandez-Hernando C, Suarez Y . MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1. Arterioscler Thromb Vasc Biol. 2011; 31(11):2595-606. PMC: 3226744. DOI: 10.1161/ATVBAHA.111.236521. View

16.

Garcia D, Baek D, Shin C, Bell G, Grimson A, Bartel D . Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol. 2011; 18(10):1139-46. PMC: 3190056. DOI: 10.1038/nsmb.2115. View

17.

Aguzzi M, DArcangelo D, Giampietri C, Capogrossi M, Facchiano A . RAM, an RGDS analog, exerts potent anti-melanoma effects in vitro and in vivo. PLoS One. 2011; 6(10):e25352. PMC: 3184964. DOI: 10.1371/journal.pone.0025352. View

18.

Grober O, Mutarelli M, Giurato G, Ravo M, Cicatiello L, Filippo M . Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation. BMC Genomics. 2011; 12:36. PMC: 3025958. DOI: 10.1186/1471-2164-12-36. View

19.

Huang H, Langenkamp E, Georganaki M, Loskog A, Fuchs P, Dieterich L . VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-κB-induced endothelial activation. FASEB J. 2014; 29(1):227-38. DOI: 10.1096/fj.14-250985. View

20.

Carlos Montero J, Seoane S, Ocana A, Pandiella A . Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors. Clin Cancer Res. 2011; 17(17):5546-52. DOI: 10.1158/1078-0432.CCR-10-2616. View